Sodium CarboxymethylcelluloseThird Party Manufacturing in India

Sodium Carboxymethylcellulose works by providing lubrication and protection to the ocular surface, relieving dry eye symptoms. As a high-molecular-weight polymer, it acts as an ophthalmic demulcent that mimics natural mucins in tears. When applied to the eye, the polymer hydrates and binds to the corneal and conjunctival epithelial cells. This binding action increases the viscosity and stability of the tear film, preventing rapid evaporation and ensuring longer retention of moisture on the eye. The viscoelastic properties of Sodium Carboxymethylcellulose allow it to shear during blinking, which provides a smooth, low-friction protective barrier that reduces irritation and mechanical friction. By coating the ocular surface, it protects injured epithelial tissues from further environmental irritation, accelerates healing of the corneal surface, and restores comfort. Unlike lower viscosity lubricants, it provides sustained relief from dryness without causing significant, prolonged blurring of vision, making it highly suitable for daily manage of ocular discomfort.

Therapeutic Uses

Sodium Carboxymethylcellulose is indicated for the treatment of:

• Dry Eye Syndrome: Alleviating dryness, burning, and irritation caused by insufficient tear production.
• Environmental Irritation: Protecting the eyes from wind, sun, smoke, dust, and prolonged computer screen exposure.
• Post-Surgical Lubrication: Soothing the eyes and promoting corneal epithelial healing after refractive or cataract surgeries.

Why Manufacturers Choose Sodium Carboxymethylcellulose

For eye care brands and third party buyers, Sodium Carboxymethylcellulose is one of the most commercially successful molecules in the OTC and prescription ophthalmic market. The global rise in screen time and environmental pollution has driven a massive increase in the demand for artificial tears and lubricating eye drops.

The manufacturing of Sodium Carboxymethylcellulose eye drops requires advanced sterile liquid filling lines, typically utilizing blow-fill-seal (BFS) technology for multi-dose or single-dose preservative-free formulations. Partnering with Celesta Healthcare for third party manufacturing provides access to state-of-the-art WHO-GMP certified facilities that manufacture Sodium Carboxymethylcellulose 0.5% and 1% w/v drops. This ensures that ophthalmic distributors, PCD franchise owners, and export businesses receive exceptionally pure, sterile products that meet rigorous IP, BP, and USP standards.